Clinical Trial Detail

NCT ID NCT04081259
Title LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute myeloid leukemia

Therapies

LY3214996

Age Groups: adult senior

No variant requirements are available.